Mefenamic acid
- Generic Name
- Mefenamic acid
- Brand Names
- Mefenamic, Ponstel
- Drug Type
- Small Molecule
- Chemical Formula
- C15H15NO2
- CAS Number
- 61-68-7
- Unique Ingredient Identifier
- 367589PJ2C
- Background
A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
- Indication
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
- Associated Conditions
- Mild pain, Primary Dysmenorrhoea, Gastrointestinal cramping, Moderate Pain
- Associated Therapies
- -
A Trial Investigating Lu AF28996 in Healthy Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT06277609
- Locations
- 🇺🇸
Covance Dallas CRU, Dallas, Texas, United States
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 28
- Registration Number
- NCT05064449
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
- Conditions
- Interventions
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Emalex Biosciences Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT04902105
- Locations
- 🇺🇸
Syneos Health Clinical Research Services, LLC., Miami, Florida, United States
Preemptive Analgesia for Primary Dysmenorrhoea
- Conditions
- Interventions
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2017-12-19
- Lead Sponsor
- Hanan Nabil
- Target Recruit Count
- 84
- Registration Number
- NCT03323671
- Locations
- 🇪🇬
Mansoura University, Mansourah, Egypt
Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects
- Conditions
- Interventions
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 16
- Registration Number
- NCT03070678
- Locations
- 🇫🇷
Investigational site 250001, Gières, France
Efficacy of Different Drugs to Control Post Root Canal Treatment Pain
- Conditions
- Interventions
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- University of Khartoum
- Target Recruit Count
- 170
- Registration Number
- NCT02417337
- Locations
- 🇸🇩
University of Khartoum, Faculty of Dentistry,, Khartoum, Sudan
DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
- Conditions
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Dexa Medica Group
- Target Recruit Count
- 60
- Registration Number
- NCT01942122
- Locations
- 🇮🇩
Yasmin Clinic, Dr. Cipto Mangunkusumo Hospital (Kencana), Jakarta Pusat, Jakarta, Indonesia
🇮🇩Department of Obstetrics and Gynecology, RSUP Persahabatan, Jakarta Pusat, Jakarta, Indonesia
🇮🇩Department of Obstetrics and Gynecology RSUP Fatmawati, Jakarta, Indonesia
Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
- Conditions
- Interventions
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Bayer
- Target Recruit Count
- 187
- Registration Number
- NCT01295294
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.